Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use

BACKGROUND: The endgame for polio eradication includes coordinated global cessation of oral poliovirus vaccine (OPV), starting with the cessation of vaccine containing OPV serotype 2 (OPV2) by switching all trivalent OPV (tOPV) to bivalent OPV (bOPV). The logistics associated with this global switch...

Descripción completa

Detalles Bibliográficos
Autores principales: Duintjer Tebbens, Radboud J., Hampton, Lee M., Thompson, Kimberly M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888482/
https://www.ncbi.nlm.nih.gov/pubmed/27246198
http://dx.doi.org/10.1186/s12879-016-1537-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888482/
https://www.ncbi.nlm.nih.gov/pubmed/27246198
http://dx.doi.org/10.1186/s12879-016-1537-8

Ejemplares similares